After taking note of the signals for response in mucosal melanoma that were reported in ARTISTRY-1, how did you proceed with the design for ARTISTRY-6 evaluating the efficacy and safety of this novel cytokine fusion protein in mucosal melanoma?
Deputy Physician-in-Chief and Director of Medical OncologyRoy J. and Tara Zuckerberg Professor in Medical OncologyNorthwell Health Cancer InstituteLake Success, NY